Market news

Detailed price information for Ispecimen Inc (ISPC-Q) from The Globe and Mail including charting and trades.

Woburn, MA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples shipped within three weeks of...

Detailed price information for Ispecimen Inc (ISPC-Q) from The Globe and Mail including charting and trades.

Detailed price information for Ispecimen Inc (ISPC-Q) from The Globe and Mail including charting and trades.

WOBURN, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced public offering of an aggregate of 996,231 shares of the Company’s common stock and pre-funded warrants to purchase up to an aggregate of 2,849,923 shares of common stock, for an aggrega

Transaction Marks E.F. Hutton's Third Capital Markets Engagement with iSpecimen Since December 2025NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as the exclusive placement agent in connection with the $5 million public offering for iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that connects researchers requiring biospecimens for medical research with a network o